This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Caroline C. Waddell, MD; Mary Anne Zubler, MD; W. Stanley Gore, MD

Arch Dermatol. 1982;118(3):179-182.

Abstract
• The development of acute myeloblastic leukemia following therapy for malignant disorders is being recognized with increasing frequency. Acute myeloblastic leukemia (erythroleukemic variant) developed in a patient with mycosis fungoides following three years of chemotherapy with a variety of antineoplastic drugs. The patient demonstrated a hypodiploid chromosomal abnormality with a missing C group chromosome.

(Arch Dermatol 1982;118:179-182)

Author Affiliations
From the Sections of Hematology (Dr Waddell) and Medical Oncology (Drs Zubler and Gore), Department of Medicine, Veterans Administration Medical Center and Baylor College of Medicine, Houston.

Footnotes
Accepted for publication July 13, 1981.

Reprint requests to Hematology Section, Department of Medicine, Veterans Administration Medical Center, Houston, TX 77211 (Dr Waddell).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?